img

Global Anti-PD-1 MAb Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Anti-PD-1 MAb Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Anti-PD-1 MAb report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Anti-PD-1 MAb market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Melanoma Patients and Lung Cancer Patients are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Anti-PD-1 MAb industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Anti-PD-1 MAb key manufacturers include Bristol Myers Squibb, Merck, Junshi Pharma, Innovent Biologics Inc, Hengrui Medicine and Beijing Beigene, etc. Bristol Myers Squibb, Merck, Junshi Pharma are top 3 players and held % sales share in total in 2022.
Anti-PD-1 MAb can be divided into 40mg, 100mg, 200mg and Others, etc. 40mg is the mainstream product in the market, accounting for % sales share globally in 2022.
Anti-PD-1 MAb is widely used in various fields, such as Melanoma Patients, Lung Cancer Patients, Lymphoma Patients and Other, etc. Melanoma Patients provides greatest supports to the Anti-PD-1 MAb industry development. In 2022, global % sales of Anti-PD-1 MAb went into Melanoma Patients filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Anti-PD-1 MAb market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Bristol Myers Squibb
Merck
Junshi Pharma
Innovent Biologics Inc
Hengrui Medicine
Beijing Beigene
Segment by Type
40mg
100mg
200mg
Others

Segment by Application


Melanoma Patients
Lung Cancer Patients
Lymphoma Patients
Other

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Anti-PD-1 MAb market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Anti-PD-1 MAb, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Anti-PD-1 MAb industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Anti-PD-1 MAb in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Anti-PD-1 MAb introduction, etc. Anti-PD-1 MAb Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Anti-PD-1 MAb market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Anti-PD-1 MAb Market Overview
1.1 Anti-PD-1 MAb Product Overview
1.2 Anti-PD-1 MAb Market Segment by Type
1.2.1 40mg
1.2.2 100mg
1.2.3 200mg
1.2.4 Others
1.3 Global Anti-PD-1 MAb Market Size by Type
1.3.1 Global Anti-PD-1 MAb Market Size Overview by Type (2024-2034)
1.3.2 Global Anti-PD-1 MAb Historic Market Size Review by Type (2024-2024)
1.3.3 Global Anti-PD-1 MAb Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Anti-PD-1 MAb Sales Breakdown by Type (2024-2024)
1.4.2 Europe Anti-PD-1 MAb Sales Breakdown by Type (2024-2024)
1.4.3 Asia-Pacific Anti-PD-1 MAb Sales Breakdown by Type (2024-2024)
1.4.4 Latin America Anti-PD-1 MAb Sales Breakdown by Type (2024-2024)
1.4.5 Middle East and Africa Anti-PD-1 MAb Sales Breakdown by Type (2024-2024)
2 Global Anti-PD-1 MAb Market Competition by Company
2.1 Global Top Players by Anti-PD-1 MAb Sales (2024-2024)
2.2 Global Top Players by Anti-PD-1 MAb Revenue (2024-2024)
2.3 Global Top Players by Anti-PD-1 MAb Price (2024-2024)
2.4 Global Top Manufacturers Anti-PD-1 MAb Manufacturing Base Distribution, Sales Area, Product Type
2.5 Anti-PD-1 MAb Market Competitive Situation and Trends
2.5.1 Anti-PD-1 MAb Market Concentration Rate (2024-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Anti-PD-1 MAb Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Anti-PD-1 MAb as of 2022)
2.7 Date of Key Manufacturers Enter into Anti-PD-1 MAb Market
2.8 Key Manufacturers Anti-PD-1 MAb Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Anti-PD-1 MAb Status and Outlook by Region
3.1 Global Anti-PD-1 MAb Market Size and CAGR by Region: 2024 VS 2022 VS 2034
3.2 Global Anti-PD-1 MAb Historic Market Size by Region
3.2.1 Global Anti-PD-1 MAb Sales in Volume by Region (2024-2024)
3.2.2 Global Anti-PD-1 MAb Sales in Value by Region (2024-2024)
3.2.3 Global Anti-PD-1 MAb Sales (Volume & Value) Price and Gross Margin (2024-2024)
3.3 Global Anti-PD-1 MAb Forecasted Market Size by Region
3.3.1 Global Anti-PD-1 MAb Sales in Volume by Region (2024-2034)
3.3.2 Global Anti-PD-1 MAb Sales in Value by Region (2024-2034)
3.3.3 Global Anti-PD-1 MAb Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Anti-PD-1 MAb by Application
4.1 Anti-PD-1 MAb Market Segment by Application
4.1.1 Melanoma Patients
4.1.2 Lung Cancer Patients
4.1.3 Lymphoma Patients
4.1.4 Other
4.2 Global Anti-PD-1 MAb Market Size by Application
4.2.1 Global Anti-PD-1 MAb Market Size Overview by Application (2024-2034)
4.2.2 Global Anti-PD-1 MAb Historic Market Size Review by Application (2024-2024)
4.2.3 Global Anti-PD-1 MAb Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Anti-PD-1 MAb Sales Breakdown by Application (2024-2024)
4.3.2 Europe Anti-PD-1 MAb Sales Breakdown by Application (2024-2024)
4.3.3 Asia-Pacific Anti-PD-1 MAb Sales Breakdown by Application (2024-2024)
4.3.4 Latin America Anti-PD-1 MAb Sales Breakdown by Application (2024-2024)
4.3.5 Middle East and Africa Anti-PD-1 MAb Sales Breakdown by Application (2024-2024)
5 North America Anti-PD-1 MAb by Country
5.1 North America Anti-PD-1 MAb Historic Market Size by Country
5.1.1 North America Anti-PD-1 MAb Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
5.1.2 North America Anti-PD-1 MAb Sales in Volume by Country (2024-2024)
5.1.3 North America Anti-PD-1 MAb Sales in Value by Country (2024-2024)
5.2 North America Anti-PD-1 MAb Forecasted Market Size by Country
5.2.1 North America Anti-PD-1 MAb Sales in Volume by Country (2024-2034)
5.2.2 North America Anti-PD-1 MAb Sales in Value by Country (2024-2034)
6 Europe Anti-PD-1 MAb by Country
6.1 Europe Anti-PD-1 MAb Historic Market Size by Country
6.1.1 Europe Anti-PD-1 MAb Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
6.1.2 Europe Anti-PD-1 MAb Sales in Volume by Country (2024-2024)
6.1.3 Europe Anti-PD-1 MAb Sales in Value by Country (2024-2024)
6.2 Europe Anti-PD-1 MAb Forecasted Market Size by Country
6.2.1 Europe Anti-PD-1 MAb Sales in Volume by Country (2024-2034)
6.2.2 Europe Anti-PD-1 MAb Sales in Value by Country (2024-2034)
7 Asia-Pacific Anti-PD-1 MAb by Region
7.1 Asia-Pacific Anti-PD-1 MAb Historic Market Size by Region
7.1.1 Asia-Pacific Anti-PD-1 MAb Market Size Growth Rate (CAGR) by Region: 2024 VS 2022 VS 2034
7.1.2 Asia-Pacific Anti-PD-1 MAb Sales in Volume by Region (2024-2024)
7.1.3 Asia-Pacific Anti-PD-1 MAb Sales in Value by Region (2024-2024)
7.2 Asia-Pacific Anti-PD-1 MAb Forecasted Market Size by Region
7.2.1 Asia-Pacific Anti-PD-1 MAb Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Anti-PD-1 MAb Sales in Value by Region (2024-2034)
8 Latin America Anti-PD-1 MAb by Country
8.1 Latin America Anti-PD-1 MAb Historic Market Size by Country
8.1.1 Latin America Anti-PD-1 MAb Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
8.1.2 Latin America Anti-PD-1 MAb Sales in Volume by Country (2024-2024)
8.1.3 Latin America Anti-PD-1 MAb Sales in Value by Country (2024-2024)
8.2 Latin America Anti-PD-1 MAb Forecasted Market Size by Country
8.2.1 Latin America Anti-PD-1 MAb Sales in Volume by Country (2024-2034)
8.2.2 Latin America Anti-PD-1 MAb Sales in Value by Country (2024-2034)
9 Middle East and Africa Anti-PD-1 MAb by Country
9.1 Middle East and Africa Anti-PD-1 MAb Historic Market Size by Country
9.1.1 Middle East and Africa Anti-PD-1 MAb Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
9.1.2 Middle East and Africa Anti-PD-1 MAb Sales in Volume by Country (2024-2024)
9.1.3 Middle East and Africa Anti-PD-1 MAb Sales in Value by Country (2024-2024)
9.2 Middle East and Africa Anti-PD-1 MAb Forecasted Market Size by Country
9.2.1 Middle East and Africa Anti-PD-1 MAb Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Anti-PD-1 MAb Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Bristol Myers Squibb
10.1.1 Bristol Myers Squibb Company Information
10.1.2 Bristol Myers Squibb Introduction and Business Overview
10.1.3 Bristol Myers Squibb Anti-PD-1 MAb Sales, Revenue and Gross Margin (2024-2024)
10.1.4 Bristol Myers Squibb Anti-PD-1 MAb Products Offered
10.1.5 Bristol Myers Squibb Recent Development
10.2 Merck
10.2.1 Merck Company Information
10.2.2 Merck Introduction and Business Overview
10.2.3 Merck Anti-PD-1 MAb Sales, Revenue and Gross Margin (2024-2024)
10.2.4 Merck Anti-PD-1 MAb Products Offered
10.2.5 Merck Recent Development
10.3 Junshi Pharma
10.3.1 Junshi Pharma Company Information
10.3.2 Junshi Pharma Introduction and Business Overview
10.3.3 Junshi Pharma Anti-PD-1 MAb Sales, Revenue and Gross Margin (2024-2024)
10.3.4 Junshi Pharma Anti-PD-1 MAb Products Offered
10.3.5 Junshi Pharma Recent Development
10.4 Innovent Biologics Inc
10.4.1 Innovent Biologics Inc Company Information
10.4.2 Innovent Biologics Inc Introduction and Business Overview
10.4.3 Innovent Biologics Inc Anti-PD-1 MAb Sales, Revenue and Gross Margin (2024-2024)
10.4.4 Innovent Biologics Inc Anti-PD-1 MAb Products Offered
10.4.5 Innovent Biologics Inc Recent Development
10.5 Hengrui Medicine
10.5.1 Hengrui Medicine Company Information
10.5.2 Hengrui Medicine Introduction and Business Overview
10.5.3 Hengrui Medicine Anti-PD-1 MAb Sales, Revenue and Gross Margin (2024-2024)
10.5.4 Hengrui Medicine Anti-PD-1 MAb Products Offered
10.5.5 Hengrui Medicine Recent Development
10.6 Beijing Beigene
10.6.1 Beijing Beigene Company Information
10.6.2 Beijing Beigene Introduction and Business Overview
10.6.3 Beijing Beigene Anti-PD-1 MAb Sales, Revenue and Gross Margin (2024-2024)
10.6.4 Beijing Beigene Anti-PD-1 MAb Products Offered
10.6.5 Beijing Beigene Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Anti-PD-1 MAb Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Anti-PD-1 MAb Industrial Chain Analysis
11.4 Anti-PD-1 MAb Market Dynamics
11.4.1 Anti-PD-1 MAb Industry Trends
11.4.2 Anti-PD-1 MAb Market Drivers
11.4.3 Anti-PD-1 MAb Market Challenges
11.4.4 Anti-PD-1 MAb Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Anti-PD-1 MAb Distributors
12.3 Anti-PD-1 MAb Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of 40mg
Table 2. Major Company of 100mg
Table 3. Major Company of 200mg
Table 4. Major Company of Others
Table 5. Global Anti-PD-1 MAb Sales by Type 2024 VS 2022 VS 2034 (US$ Million)
Table 6. Global Anti-PD-1 MAb Sales by Type (2024-2024) & (KG)
Table 7. Global Anti-PD-1 MAb Sales Market Share in Volume by Type (2024-2024)
Table 8. Global Anti-PD-1 MAb Sales by Type (2024-2024) & (US& Million)
Table 9. Global Anti-PD-1 MAb Market Share in Value by Type (2024-2024)
Table 10. Global Anti-PD-1 MAb Price by Type (2024-2024) & (USD/KG)
Table 11. Global Anti-PD-1 MAb Sales by Type (2024-2034) & (KG)
Table 12. Global Anti-PD-1 MAb Sales Market Share in Volume by Type (2024-2034)
Table 13. Global Anti-PD-1 MAb Sales by Type (2024-2034) & (US$ Million)
Table 14. Global Anti-PD-1 MAb Sales Market Share in Value by Type (2024-2034)
Table 15. Global Anti-PD-1 MAb Price by Type (2024-2034) & (USD/KG)
Table 16. North America Anti-PD-1 MAb Sales by Type (2024-2024) & (KG)
Table 17. North America Anti-PD-1 MAb Sales by Type (2024-2024) & (US$ Million)
Table 18. Europe Anti-PD-1 MAb Sales (KG) by Type (2024-2024)
Table 19. Europe Anti-PD-1 MAb Sales by Type (2024-2024) & (US$ Million)
Table 20. Asia-Pacific Anti-PD-1 MAb Sales (KG) by Type (2024-2024)
Table 21. Asia-Pacific Anti-PD-1 MAb Sales by Type (2024-2024) & (US$ Million)
Table 22. Latin America Anti-PD-1 MAb Sales (KG) by Type (2024-2024)
Table 23. Latin America Anti-PD-1 MAb Sales by Type (2024-2024) & (US$ Million)
Table 24. Middle East and Africa Anti-PD-1 MAb Sales (KG) by Type (2024-2024)
Table 25. Middle East and Africa Anti-PD-1 MAb Sales by Type (2024-2024) & (US$ Million)
Table 26. Global Anti-PD-1 MAb Sales by Company (2024-2024) & (KG)
Table 27. Global Anti-PD-1 MAb Sales Share by Company (2024-2024)
Table 28. Global Anti-PD-1 MAb Revenue by Company (2024-2024) & (US$ Million)
Table 29. Global Anti-PD-1 MAb Revenue Share by Company (2024-2024)
Table 30. Global Market Anti-PD-1 MAb Price by Company (2024-2024) & (USD/KG)
Table 31. Global Anti-PD-1 MAb Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 32. Global Anti-PD-1 MAb Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 33. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Anti-PD-1 MAb as of 2022)
Table 34. Date of Key Manufacturers Enter into Anti-PD-1 MAb Market
Table 35. Key Manufacturers Anti-PD-1 MAb Product Type
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global Anti-PD-1 MAb Market Size Comparison by Region (US$ Million): 2024 VS 2022 VS 2034
Table 38. Global Anti-PD-1 MAb Sales by Region (2024-2024) & (KG)
Table 39. Global Anti-PD-1 MAb Sales Market Share in Volume by Region (2024-2024)
Table 40. Global Anti-PD-1 MAb Sales by Region (2024-2024) & (US$ Million)
Table 41. Global Anti-PD-1 MAb Sales Market Share in Value by Region (2024-2024)
Table 42. Global Anti-PD-1 MAb Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2024-2024)
Table 43. Global Anti-PD-1 MAb Sales by Region (2024-2034) & (KG)
Table 44. Global Anti-PD-1 MAb Sales Market Share in Volume by Region (2024-2034)
Table 45. Global Anti-PD-1 MAb Sales by Region (2024-2034) & (US$ Million)
Table 46. Global Anti-PD-1 MAb Sales Market Share in Value by Region (2024-2034)
Table 47. Global Anti-PD-1 MAb Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2024-2034)
Table 48. Global Anti-PD-1 MAb Sales by Application: 2024 VS 2022 VS 2034 (US$ Million)
Table 49. Global Anti-PD-1 MAb Sales by Application (2024-2024) & (KG)
Table 50. Global Anti-PD-1 MAb Sales Market Share in Volume by Application (2024-2024)
Table 51. Global Anti-PD-1 MAb Sales by Application (2024-2024) & (US$ Million)
Table 52. Global Anti-PD-1 MAb Sales Market Share in Value by Application (2024-2024)
Table 53. Global Anti-PD-1 MAb Price by Application (2024-2024) & (USD/KG)
Table 54. Global Anti-PD-1 MAb Sales by Application (2024-2034) & (KG)
Table 55. Global Anti-PD-1 MAb Sales Market Share in Volume by Application (2024-2034)
Table 56. Global Anti-PD-1 MAb Sales by Application (2024-2034) & (US$ Million)
Table 57. Global Anti-PD-1 MAb Sales Market Share in Value by Application (2024-2034)
Table 58. Global Anti-PD-1 MAb Price by Application (2024-2034) & (USD/KG)
Table 59. North America Anti-PD-1 MAb Sales by Application (2024-2024) (KG)
Table 60. North America Anti-PD-1 MAb Sales by Application (2024-2024) & (US$ Million)
Table 61. Europe Anti-PD-1 MAb Sales by Application (2024-2024) (KG)
Table 62. Europe Anti-PD-1 MAb Sales by Application (2024-2024) & (US$ Million)
Table 63. Asia-Pacific Anti-PD-1 MAb Sales by Application (2024-2024) (KG)
Table 64. Asia-Pacific Anti-PD-1 MAb Sales by Application (2024-2024) & (US$ Million)
Table 65. Latin America Anti-PD-1 MAb Sales by Application (2024-2024) (KG)
Table 66. Latin America Anti-PD-1 MAb Sales by Application (2024-2024) & (US$ Million)
Table 67. Middle East and Africa Anti-PD-1 MAb Sales by Application (2024-2024) (KG)
Table 68. Middle East and Africa Anti-PD-1 MAb Sales by Application (2024-2024) & (US$ Million)
Table 69. North America Anti-PD-1 MAb Sales by Country (2024-2024) & (KG)
Table 70. North America Anti-PD-1 MAb Sales Market Share in Volume by Country (2024-2024)
Table 71. North America Anti-PD-1 MAb Sales by Country (2024-2024) & (US$ Million)
Table 72. North America Anti-PD-1 MAb Sales Market Share in Value by Country (2024-2024)
Table 73. North America Anti-PD-1 MAb Sales by Country (2024-2034) & (KG)
Table 74. North America Anti-PD-1 MAb Sales Market Share in Volume by Country (2024-2034)
Table 75. North America Anti-PD-1 MAb Sales by Country (2024-2034) & (US$ Million)
Table 76. North America Anti-PD-1 MAb Sales Market Share in Value by Country (2024-2034)
Table 77. Europe Anti-PD-1 MAb Sales by Country (2024-2024) & (KG)
Table 78. Europe Anti-PD-1 MAb Sales Market Share in Volume by Country (2024-2024)
Table 79. Europe Anti-PD-1 MAb Sales by Country (2024-2024) & (US$ Million)
Table 80. Europe Anti-PD-1 MAb Sales Market Share in Value by Country (2024-2024)
Table 81. Europe Anti-PD-1 MAb Sales by Country (2024-2034) & (KG)
Table 82. Europe Anti-PD-1 MAb Sales Market Share in Volume by Country (2024-2034)
Table 83. Europe Anti-PD-1 MAb Sales by Country (2024-2034) & (US$ Million)
Table 84. Europe Anti-PD-1 MAb Sales Market Share in Value by Country (2024-2034)
Table 85. Asia-Pacific Anti-PD-1 MAb Sales by Region (2024-2024) & (KG)
Table 86. Asia-Pacific Anti-PD-1 MAb Sales Market Share in Volume by Region (2024-2024)
Table 87. Asia-Pacific Anti-PD-1 MAb Sales by Region (2024-2024) & (US$ Million)
Table 88. Asia-Pacific Anti-PD-1 MAb Sales Market Share in Value by Region (2024-2024)
Table 89. Asia-Pacific Anti-PD-1 MAb Sales by Region (2024-2034) & (KG)
Table 90. Asia-Pacific Anti-PD-1 MAb Sales Market Share in Volume by Region (2024-2034)
Table 91. Asia-Pacific Anti-PD-1 MAb Sales by Region (2024-2034) & (US$ Million)
Table 92. Asia-Pacific Anti-PD-1 MAb Sales Market Share in Value by Region (2024-2034)
Table 93. Latin America Anti-PD-1 MAb Sales by Country (2024-2024) & (KG)
Table 94. Latin America Anti-PD-1 MAb Sales Market Share in Volume by Country (2024-2024)
Table 95. Latin America Anti-PD-1 MAb Sales by Country (2024-2024) & (US$ Million)
Table 96. Latin America Anti-PD-1 MAb Sales Market Share in Value by Country (2024-2024)
Table 97. Latin America Anti-PD-1 MAb Sales by Country (2024-2034) & (KG)
Table 98. Latin America Anti-PD-1 MAb Sales Market Share in Volume by Country (2024-2034)
Table 99. Latin America Anti-PD-1 MAb Sales by Country (2024-2034) & (US$ Million)
Table 100. Latin America Anti-PD-1 MAb Sales Market Share in Value by Country (2024-2034)
Table 101. Middle East and Africa Anti-PD-1 MAb Sales by Country (2024-2024) & (KG)
Table 102. Middle East and Africa Anti-PD-1 MAb Sales Market Share in Volume by Country (2024-2024)
Table 103. Middle East and Africa Anti-PD-1 MAb Sales by Country (2024-2024) & (US$ Million)
Table 104. Middle East and Africa Anti-PD-1 MAb Sales Market Share in Value by Country (2024-2024)
Table 105. Middle East and Africa Anti-PD-1 MAb Sales by Country (2024-2034) & (KG)
Table 106. Middle East and Africa Anti-PD-1 MAb Sales Market Share in Volume by Country (2024-2034)
Table 107. Middle East and Africa Anti-PD-1 MAb Sales by Country (2024-2034) & (US$ Million)
Table 108. Middle East and Africa Anti-PD-1 MAb Sales Market Share in Value by Country (2024-2034)
Table 109. Bristol Myers Squibb Company Information
Table 110. Bristol Myers Squibb Introduction and Business Overview
Table 111. Bristol Myers Squibb Anti-PD-1 MAb Sales (KG), Revenue (Million USD), Price (USD/KG) and Gross Margin (2024-2024)
Table 112. Bristol Myers Squibb Anti-PD-1 MAb Product
Table 113. Bristol Myers Squibb Recent Development
Table 114. Merck Company Information
Table 115. Merck Introduction and Business Overview
Table 116. Merck Anti-PD-1 MAb Sales (KG), Revenue (Million USD), Price (USD/KG) and Gross Margin (2024-2024)
Table 117. Merck Anti-PD-1 MAb Product
Table 118. Merck Recent Development
Table 119. Junshi Pharma Company Information
Table 120. Junshi Pharma Introduction and Business Overview
Table 121. Junshi Pharma Anti-PD-1 MAb Sales (KG), Revenue (Million USD), Price (USD/KG) and Gross Margin (2024-2024)
Table 122. Junshi Pharma Anti-PD-1 MAb Product
Table 123. Junshi Pharma Recent Development
Table 124. Innovent Biologics Inc Company Information
Table 125. Innovent Biologics Inc Introduction and Business Overview
Table 126. Innovent Biologics Inc Anti-PD-1 MAb Sales (KG), Revenue (Million USD), Price (USD/KG) and Gross Margin (2024-2024)
Table 127. Innovent Biologics Inc Anti-PD-1 MAb Product
Table 128. Innovent Biologics Inc Recent Development
Table 129. Hengrui Medicine Company Information
Table 130. Hengrui Medicine Introduction and Business Overview
Table 131. Hengrui Medicine Anti-PD-1 MAb Sales (KG), Revenue (Million USD), Price (USD/KG) and Gross Margin (2024-2024)
Table 132. Hengrui Medicine Anti-PD-1 MAb Product
Table 133. Hengrui Medicine Recent Development
Table 134. Beijing Beigene Company Information
Table 135. Beijing Beigene Introduction and Business Overview
Table 136. Beijing Beigene Anti-PD-1 MAb Sales (KG), Revenue (Million USD), Price (USD/KG) and Gross Margin (2024-2024)
Table 137. Beijing Beigene Anti-PD-1 MAb Product
Table 138. Beijing Beigene Recent Development
Table 139. Key Raw Materials Lists
Table 140. Raw Materials Key Suppliers Lists
Table 141. Anti-PD-1 MAb Market Trends
Table 142. Anti-PD-1 MAb Market Drivers
Table 143. Anti-PD-1 MAb Market Challenges
Table 144. Anti-PD-1 MAb Market Restraints
Table 145. Anti-PD-1 MAb Distributors List
Table 146. Anti-PD-1 MAb Downstream Customers
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
List of Figures
Figure 1. Anti-PD-1 MAb Product Picture
Figure 2. Global Anti-PD-1 MAb Market Size, 2024 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Anti-PD-1 MAb Market Size Status and Outlook (2024-2034) & (US$ Million)
Figure 4. Global Anti-PD-1 MAb Sales Status and Outlook (2024-2034) & (KG)
Figure 5. Product Picture of 40mg
Figure 6. Global 40mg Sales YoY Growth (2024-2034) & (KG)
Figure 7. Product Picture of 100mg
Figure 8. Global 100mg Sales YoY Growth (2024-2034) & (KG)
Figure 9. Product Picture of 200mg
Figure 10. Global 200mg Sales YoY Growth (2024-2034) & (KG)
Figure 11. Product Picture of Others
Figure 12. Global Others Sales YoY Growth (2024-2034) & (KG)
Figure 13. Global Anti-PD-1 MAb Sales by Type (2024-2034) & (US$ Million)
Figure 14. Global Anti-PD-1 MAb Sales Market Share by Type in 2022 & 2034
Figure 15. North America Anti-PD-1 MAb Sales Market Share in Volume by Type in 2022
Figure 16. North America Anti-PD-1 MAb Sales Market Share in Value by Type in 2022
Figure 17. Europe Anti-PD-1 MAb Sales Market Share in Volume by Type in 2022
Figure 18. Europe Anti-PD-1 MAb Sales Market Share in Value by Type in 2022
Figure 19. Asia-Pacific Anti-PD-1 MAb Sales Market Share in Volume by Type in 2022
Figure 20. Asia-Pacific Anti-PD-1 MAb Sales Market Share in Value by Type in 2022
Figure 21. Latin America Anti-PD-1 MAb Sales Market Share in Volume by Type in 2022
Figure 22. Latin America Anti-PD-1 MAb Sales Market Share in Value by Type in 2022
Figure 23. Middle East and Africa Anti-PD-1 MAb Sales Market Share in Volume by Type in 2022
Figure 24. Middle East and Africa Anti-PD-1 MAb Sales Market Share in Value by Type in 2022
Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Anti-PD-1 MAb Sales in 2022
Figure 26. The 5 and 10 Largest Manufacturers in the World: Market Share by Anti-PD-1 MAb Revenue in 2022
Figure 27. Anti-PD-1 MAb Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2024 VS 2022
Figure 28. Product Picture of Melanoma Patients
Figure 29. Global Melanoma Patients Sales YoY Growth (2024-2034) & (KG)
Figure 30. Product Picture of Lung Cancer Patients
Figure 31. Global Lung Cancer Patients Sales YoY Growth (2024-2034) & (KG)
Figure 32. Product Picture of Lymphoma Patients
Figure 33. Global Lymphoma Patients Sales YoY Growth (2024-2034) & (KG)
Figure 34. Product Picture of Other
Figure 35. Global Other Sales YoY Growth (2024-2034) & (KG)
Figure 36. Global Anti-PD-1 MAb Sales by Application (2024-2034) & (US$ Million)
Figure 37. Global Anti-PD-1 MAb Sales Market Share by Application in 2022 & 2034
Figure 38. North America Anti-PD-1 MAb Sales Market Share in Volume by Application in 2022
Figure 39. North America Anti-PD-1 MAb Sales Market Share in Value by Application in 2022
Figure 40. Europe Anti-PD-1 MAb Sales Market Share in Volume by Application in 2022
Figure 41. Europe Anti-PD-1 MAb Sales Market Share in Value by Application in 2022
Figure 42. Asia-Pacific Anti-PD-1 MAb Sales Market Share in Volume by Application in 2022
Figure 43. Asia-Pacific Anti-PD-1 MAb Sales Market Share in Value by Application in 2022
Figure 44. Latin America Anti-PD-1 MAb Sales Market Share in Volume by Application in 2022
Figure 45. Latin America Anti-PD-1 MAb Sales Market Share in Value by Application in 2022
Figure 46. Middle East and Africa Anti-PD-1 MAb Sales Market Share in Value by Application in 2022
Figure 47. Key Raw Materials Price
Figure 48. Anti-PD-1 MAb Manufacturing Cost Structure
Figure 49. Anti-PD-1 MAb Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries